logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Arteriolar Vasodilator class drugs

    FiltersReset Filters
    5 results

    • bidil

      (Hydralazine hydrochloride and Isosorbide dinitrate)
      Azurity
      Usage: BiDil is indicated for treating heart failure in self-identified Black patients as an adjunct to standard therapy to improve survival, prolong hospitalization time for heart failure, and enhance functional status. It has limited experience in patients with NYHA class IV heart failure.

    • hydralazine hydrochloride

      (HYDRALAZINE HYDROCHLORIDE)
      Fresenius Kabi USA, LLC
      Usage: The drug is indicated for severe essential hypertension in cases where oral administration is not feasible or there is an urgent need to reduce blood pressure.

    • hydralazine hydrochloride

      (HYDRALAZINE HYDROCHLORIDE)
      Eugia US LLC
      Usage: This drug is indicated for severe essential hypertension, particularly when oral administration is not feasible or when there is an urgent need to lower blood pressure.

    • hydralazine hydrochloride

      (hydralazine hydrochloride)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: The drug is indicated for the treatment of essential hypertension, either on its own or as an adjunct to other therapies.

    • hydralazine hydrochloride

      (Hydralazine Hydrochloride)
      Chartwell RX, LLC
      Usage: This drug is indicated for the treatment of essential hypertension, either as a standalone therapy or in combination with other medications.